Summary
The article summarises history, terminology, the clinical and neuropathological diagnostic criteria, neurochemical and genetic findings, sensitivity and specificity of the clinical diagnostic criteria, prevalence, demographical data and nosology, differential diagnosis, and therapy of dementia with Lewy bodies (DLB). DLB shares clinical symptoms of Parkinson’s disease and dementia of the Alzheimer-type (DAT). However, DLB is also different to PD and DAT (less tremor and asymmetry of the motor symptoms, more falls, and less favourable response to L-Dopa than PD; in contrast to DAT marked cognitive fluctuations and phases of reduced alertness, hallucinations and delirium). There are genetic similarities to DAT and PD in terms of common genetic risk factors. A genetic cause of the disease has so far not been detected. Whether or not DLB is a disease entity or an association of diseases (Lewy body disease and DAT) has so far not been elucidated. Clinical distinction from DAT and PD has clinical importance because of different therapeutic and prognostic implications. Studies are needed to standardize the treatment of motor, cognitive, psychiatric and vegetative symptoms.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aarsland D, Bronnick K, Karlsen K (1999) Donepezil for dementia with Lewy bodies: a case study. Int J Geriatr Psychiatry 14: 69–72
Albin RL, Minoshima S, D’Amato CJ, Frey KA, Kuhl DA, Sima AAF (1996) Fluorodeoxyglucose positron emission tomography in diffuse Lewy body disease. Neurology 47: 462–466
Atkinson A, Singleton AB, Steward A, Ince PG, Perry RH, McKeith IG, Fairbairn AH, Edwardson JA, Daly AK, Morris CM (1999) CYP associated with Parkinson’s disease but not with dementia with Lewy bodies or Alzheimer’s disease. Pharmacogenetics 9: 31–35
Ballard C, Holmes C, McKeith I, Neill D, O’Brien J, Cairns N, Lantos P, Perry E, Ince P, Perrry R (1999) Psychiatric morbidity in dementia with Lewy bodies: a prospective clinical and neuropathological comparative study with Alzheimer’s disease. Am J Psychiatry 156: 1039–1045
Barber R, Gholkar A, Scheltens P, Ballard C, McKeith IG, O’Brien JT (1999) Medial temporal lobe atrophy on MRI in dementia with Lewy bodies. Neurology 52: 1153–1158
Boeve BF, Silber MH, Ferman TJ, Kokmen E, Smith GE, Ivnik RJ, Parisi JE, Olson EJ, Petersen RC (1998) REM sleep behavior disorder and degenerative dementia: an association likely reflects Lewy body disease. Neurology 51: 363–370
Briel RCG, McKeith IG, Barker WA, Hewitt Y, Perry RH, Ince PG, Fairbairn AF (1999) EEG findings in dementia with lewy bodies and Alzheimer’s disease. J Neurol Neurosurg Psychiatry 66: 401–403
Brown DF, Dababo MA, Bigio EH, Risser RC, Eagan KP, Hladik CL, White CL 3rd (1998) Neuropathologic evidence that the Lewy body variant of Alzheimer disease represents coexistence of Alzheimer disease and idiopathic Parkinson disease. J Neuropathol Exp Neurol 57: 39–46
Burkhardt CR, Filley CM, Kleinschmidt-DeMasters BK, de la Monte S, Norenberg MD, Schneck SA (1988) Diffuse Lewy body disease and progressive dementia. Neurology 38: 1520–1528
Byrne EJ, Lowe J, Godwin-Austen RB, Arie T, Jones R (1987) Dementia and Parkinson’s disease associated with diffuse cortical Lewy bodies. Lancet is 501
Candy JM, Perr RH, Perry EK, Irving D, Blessed G, Fairbairn AF, Tomlinson BE (1983) Pathological changes in the nucleus of Meynert in Alzheimer’s and Parkinson’s diseases. J Neurol Sci 54: 277–289
Cercy SP, Bylsma FW (1997) Lewy bodies and progressive dementia: A critical review and meta-analysis. J Int Neuropsychol Soc 3: 179–194
Del-Ser, Munoz DG, Hachinski V (1996) Temporal pattern of cognitive decline and incontinence is different in Alzheimer’s disease and diffuse Lewy body disease. Neurology 46: 682–686
Dickson DW, Davies P, Mayeux R, Crystal H, Horoupian DS, Thompson A, Goldman JE (1987) Diffuse Lewy body disease: Neuropathological and biochemical studies of six patients. Acta Neuropathol 75: 8–15
Dickson DW, Ruan D, Crystal H, Mark MH, Davies P, Kress A, Yen SH (1991) Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer’s disease: Light and electron microscopic immunocytochemistry of CA2–3 neurites specific to DLBD. Neurology 41: 2–3
Ditter SM, Mirra SS (1987) Neuropathologic and clinical features of Parkinson’s disease in Alzheimer’s disease patients. Neurology 29: 1209–1214
Donnemiller E, Heilmann J, Wenning GK, Berger W, Decristoforo C, Moncayo R, Poewe W, Ransmayr G (1996) Brain perfusion scintigraphy with 99mTc-HMPAO or 99Tc-ECD and 1231-ß-CIT single-photon emission tomography in dementia of the Alzheimer-type and diffuse Lewy body disease. Eur J Nucl Med 24: 320–325
Drach LM, Steinmetz HE, Wach S, Bohl J (1997) High proportion of dementia with Lewy bodies in the postmortems of a mental hospital in Germany. Int J Geriatr Psychiatry 12: 301–306
Forno LS, Barbour PJ, Norville RL (1978) Presenile dementia with Lewy bodies and neurofibrillary tangles. Arch Neurol 35: 818–822
Galasko D, Saitoh T, Xia T (1995) The apolipoprotein E allele e4 is over-represented in patients with the Lewy body variant of Alzheimer’s disease. Neurology 44: 1950–1951
Galasko D, Katzman R, Salmon DP, Hansen L (1996) Clinical and neuropathological findings in Lewy body dementias. Brain Cogn 31: 166–175
Gearing M, Lynn M, Mirra SS (1999) Neurofibrillary pathology in Alzheimer disease with Lewy bodies: two subgroups. Arch Neurol 56: 203–208
Gibb WRG, Esiri MM, Lees AJ (1985) Clinical and pathological features of diffuse cortical Lewy body disease (Lewy body dementia). Brain 110: 1131–1153
Gnanalingham KK, Byrne EJ, Thornton A, Sambrook MA, Bannister P (1997) Motor and cognitive function in Lewy body dementia: comparison with Alzheimer’s and Parkinson’s diseases. J Neurol Neurosurg Psychiatry 62: 243–252
Gomez-Tortosa E, Newell K, Irizarry MC, Albert M, Growdon JH, Hyman BT (1999) Clinical and quantitative pathological correlates of dementia with Lewy bodies. Neurology 53: 1284–1291
Hansen LA, Samuel W (1997) Criteria for Alzheimer’s disease and the nosology of dementia with Lewy bodies. Neurology 48: 126–132
Hansen L, Salmon D, Galasko D, Masliah E, Katzman R, DeTeresa R, Thal L, Pay MM, Hofstetter R, Klauber M, Rice V, Butters N, Alford M (1990) The Lewy body variant of Alzheimer’s disease: A clinical and pathological entity. Neurology 40: 18
Harrington CR, Louwagie J, Rossau R, Vanmechelen E, Perry RH, Perry EK, Xuereb JH, Roth M, Wischik CM (1994) Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types: Significance for etiological theories of Alzheimer’s disease. Am J Pathol 1472–1484.
Hashimoto M, Kitagaki H, Imamura T, Hirono N, Shimomura T, Kazui H, Tanimukai S, Hanihara T, Mori E (1998) Medial temporal and whole-brain atrophy in dementia with Lewy bodies: a volumetric MRI study. Neurology 51: 357–362
Heyman A, Fillenbaum GG, Gearing M, Mirra SS, Welsh-Bohmer KA, Peterson B, Pieper C (1999) Comparison of Lewy body variant of Alzheimer’s disease with pure Alzheimer’s disease. Neurology 52: 1839–1844
Higuchi S, Arai H, Matsushita S, Matsui, Kimpara T, Takeda A, Shirakura K (1998) Mutation in the alpha-synuclein gene and sporadic Parkinson’s disease, Alzheimer’s disease, and dementia with Lewy bodies. Exp Neurol 153: 164–166
Holmes C, Cairns N, Lantos P, Mann A (1999) Validity of current clinical criteria for Alzheimer’s disease, vascular dementia and dementia with Lewy bodies. Br J Psychiatry 174: 45–50
Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) The accuracy of clinical diagnosis of idiopathic Parkinson’s disease: A clinicopathological study. J Neurol Neurosurg Psychiatry 55: 181–184
Hulette C, Mirra S, Wilkinson W, Heyman A, Fillenbaum G, Clark C (1995) The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part IX. A prospective cliniconeuropathological study of Parkinson’s features in Alzheimer’s disease. Neurology 45: 1991–1995
Ikeda K, Yoshimura, T, Kato H, Namba M (1978) Idiopathic parkinsonism with Lewy-type inclusions in cerebral cortex. A case report. Acta Neuropathol 41: 165168
Ikeda K, Hori A, Boe G (1980) Progressive dementia with diffuse Lewy-type inclusions in cerebral cortex: A case report. Arch Psychiatr Nervenkr 228: 243–248
Imamura T, Hirono N, Hashimoto M, Shimomura T, Tanimukai S, Kazui H, Hanihara T, Mori E (1999) Clinical diagnosis of dementia with Lewy bodies in a Japanese Dementia Registry. Dement Geriatr Disord 10: 210–216
Ince PG, Irving D, McArthur F, Perry RH (1991) Quantitative neuropathological study of Alzheimer-type pathology in the hippocampus: comparison of senile dementia of Alzheimer type, senile dementia of Lewy body type, Parkinson’s disease and non-demented elderly control patients. J Neurol Sci 106: 142–152
Ince PG, Perry EK, Morris CM (1998) Dementia with Lewy bodies. A distinct non-Alzheimer dementia syndrome? Brain Pathol 8: 299–324
Ishii K, Yamaji S, Kitagaki H, Imamura T, Hirono N, Mori E (1999) Regional cerebral blood flow difference between dementia with Lewy bodies and AD. Neurology 53: 413–416
Ishikawa A, Takahashi H, Tanaka H, Hayashi T, Tsuji S (1997) Clinical features of familial diffuse Lewy body disease. Eur Neurol 38: 34–38
Jellinger KA (1999) The frequency of Lewy bodies in a consecutive autopsy series. Clin Neuropathol 18: 214–215
Kaufer DI, Catt KE, Lopez OL, DeKosky ST (1998) Dementia with Lewy bodies: response of delirium-like features to donepezil. Neurology 51: 1512
Klatka LA, Louis ED, Schiffer RB (1996) Psychiatric features in diffuse Lewy body disease: a clinicopathologic study using Alzheimer’s disease and Parkinson’s disease comparison groups. Neurology 47: 1148–1152
Kosaka K (1978) Lewy bodies in cerebral cortex. Report of three cases. Acta Neuropathol (Berl) 42: 127–134
Kosaka K (1990) Diffuse Lewy body disease in Japan. J Neurol 237: 197–204
Kosaka K, Mehraein P (1979) Dementia-parkinsonism syndrome with numerous Lewy bodies and senile plaques in cerebral cortex. Arch Psychiatr Nervenkrankh 226: 241–250
Kosaka K, Matsushita M, Oyanagi S, Mehraein P (1980) A cliniconeuropathological study of the “Lewy body disease”. Psychiatr Neurol Jpn 5: 292–311
Kosaka K, Yoshimura M, Ikeda K, Budka H (1983) Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree: a new disease? Clin Neuropathol 3: 185–92
Kosaka K, Yoshimura M, Ikeda K, Budka H (1984) Diffuse type of Lewy body disease: Progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree—a new disease? Clin Neuropathol 3: 185–192
Lamb H, Christie J, Singleton AB, Leake A, Perry RH, Ince PG, McKeith IG, Melton LM, Edwardson JA, Morris CM (1998) Apolipoprotein E and alpha-1 antichymotrypsin polymorphism genotyping in Alzheimer’s disease and in dementia with Lewy bodies. Distinctions between diseases. Neurology 50: 388–391
Langlais PJ, Thal L, Hansen LA (1993) Neurotransmitters in basal ganglia and cortex of Alzheimer’s disease with and without Lewy bodies. Neurology 43: 1927–1934
Lebert F, Pasquier F, Souliez L, Petit H (1998) Tacrine efficacy in Lewy body dementia. Int J Geriatr Psychiatr 13: 516- 519
Lennox G, Lowe J, Landon M, Byrne EJ, Mayer RJ, Godwin-Austen RB (1989) Diffuse Lewy body disease: Correlative neuropathology using anti- ubiquitin immunocytochemistry. J Neurol Neurosurg Psychiatr 52: 1236–1247
Levy R, Eagger S, Griffiths M, Perry E, Honavar M, Dean A, Lantos P (1994) Lewy bodies and response to tacrine in Alzheimer’s disease. Lancet 343: 176
Lewy FH (1923) Die Lehre vom Tonus and der Bewegung: Zugleich systematische Untersuchungen zur Klinik, Physiologie, Pathologie and Pathogenese der Paralysis agitans. Springer, Berlin
Lindboe CF, Hansen HB (1998) The frequency of Lewy bodies in a consecutive autopsy series. Clin Neuropathol 17: 204–209
Lippa CF, Smith TW, Swearer JM (1994) Alzheimer’s disease and Lewy body disease: a comparative clinicopathologic study. Ann Neurol 35: 81- 88
Lippa CF, Smith TW, Saunders AM, Crook R, Pulaski-Salo D, Davies P, Hardy J, Roses AD, Dickson D (1995) Apolipoprotein E genotype and Lewy body disease. Neurology 45: 97–103
Lippa CF, Smith TW, Perry E (1999) Dementia with Lewy bodies: choline acetyltransferase parallels nucleus basalis pathology. J Neural Transm 106: 525–535
Litvan I, Maclntyre A, Goetz CG, Wenning GK, Jellinger K, Verny M, Bartko JJ, Jankovic J, McKee A, Brandel JP, Chauduri KR, Lai EC, D’Olhaberriague L, Pearce RK, Agid Y (1997) Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease and dementia with Lewy bodies: a clinicopathologic study. Arch Neurol 55: 969–978
Lopez OL, Litvan I, Catt KE, Stowe R, Klunk W, Kaufer DI, Becker JT, DeKosky ST (1999) Accuracy of four clinical diagnostic criteria for the diagnosis of neurodegenerative dementias. Neurology 53: 1292–1299
Louis ED, Klatka LA, Liu Y, Fahn S (1997) Comparison of extrapyramidal features in 31 pathologically confirmed cases of diffuse Lewy body disease and 34 pathologically confirmed cases of Parkinson’s disease. Neurology 48:376–380
Luis CA, Barker WW, Gajaray K, Harwood D, Petersen R, Kashuba A, Waters C, Jimison P, Pearl G, Petito C, Dickson D, Duara R (1999) Sensitivity and specificity of three clinical criteria for dementia with Lewy bodies in an autopsy-verified sample. Int J Geriatr Psychiatry 14: 526–533
Mattila PM, Roytta M, Torikka H, Dickson DW, Rinne JO (1998) Cortical Lewy bodies and Alzheimer-type changes in patients with Parkinson’s disease. Acta Neuropathol 95: 576–582
Mayeux R, Denaro J, Hemenegildo N, Marder K, Tang MX, Cotè LJ, Stern Y (1992) A population based investigation of Parkinson’s disease with and without dementia. Relationship to age and gender. Arch Neurol 49:492–497
McKeith IG, Fairbaim AF, Bothwell RA, Moore PB, Ferrier IN, Thompson P, Perry RH (1994a) An evaluation of the predictive validity and inter-rater reliability of clinical diagnostic criteria for senile dementia of Lewy body type. Neurology 44: 872–877
McKeith IG, Fairbairn AF, Perry RH, Thompson P (1994b) The clinical diagnosis and misdiagnosis of senile dementia of Lewy body type (SDLT). Br J Psychiatry 165: 324–332
McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA et al. (1996) Consensus guidlines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB). Neurology 47: 1113–1124
McKeith IG, Perry EK, Perry RH (1999) Report of the second dementia with Lewy body international workshop. Neurology 53: 902–905
Mega MS, Masterman DL, Benson DF, Vinters HV, Tomiyasu U, Craig AH, Foti DJ, Kaufer D, Scharre DW, Fairbanks L, Cummings J (1996) Dementia with Lewy bodies: Reliability and validity of clinical and pathological criteria. Neurology 47: 1403–1409
Ohara K, Takauchi S, Kokai M, Morimura Y, Nakajima T, Morita Y (1999) Familial dementia with Lewy bodies. Clin Neuropathol 18: 232–239
Okazaki H, Lipkin LE, Aronson SM (1961) Diffuse intracytoplasmic ganglionic inclusions (lewy type) associated with progressive dementia and quadriparesis in flexion. J Neuropathol Exp Neurol 20: 237–244
Olichney JM, Hansen LA, Galasko D, Saitoh T, Hofstetter CR, Katzman R, Thal LJ (1996) The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer’s disease and Lewy body variant. Neurology 47: 190–196
Olichney JM, Galasko D, Salmon DP, Hofstetter CR, Hansen LA, Katzman R, Thal LJ (1998) Cognitive decline is faster in Lewy body variant than in Alzheimer’s disease. Neurology 51: 351–357
Opeskin K, Gonzales M, Borenstein R, Anderson R (1993) Diffuse Lewy body disease with immediate post-partum onset. Acta Neuropathol 85: 213 -216
Perry EK, Smith CJ, Court JA, Perry RH (1990) Cholinergic nicotinic and muscarinic receptors in dementia of Alzheimer, Parkinson and Lewy body types. J Neural Transm Park Dis Dement Sect 2(3): 149–158
Perry EK, Haroutunian V, Davis KL (1994) Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer’s disease. Neuro Report 5: 747–749
Perry RH, Irving D, Blessed G, Fairbairn A, Perry EK (1990) Senile dementia of the Lewy body type: A clinically and neuropathologically distinct form of Lewy body dementia in the elderly. J Neurol Sci 95: 119–139
G. Ransmayr: Dementia with Lewy bodies
Piggott MA, Marshall EF, Thomas N, Lloyd S, Court JA, Jaros E, Burn D, Johnson M, Perry RH, McKeith IG, Ballard C, Perry EK (1999) Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer’s and Parkinson’s diseases:rostrocaudal distribution. Brain 122: 1449–1468
Sahgal A, Galloway PH, McKeith IG, Lloyd S, Cook JH, Ferrier IN, Edwardson JA (1992) A comparative study of attentional deficits in senile dementias of Alzheimer and Lewy body types. Dementia 3: 350–354
Samuel W, Alford M, Hofstetter R, Hansen L (1997) Dementia with Lewy bodies versus pure Alzheimer Disease: Differences in cognition, neuropathology, cholinergic dysfunction, an synapse density. J Neuropath Exp Neurology 56: 499–508
Shimomura T, Mori E, Yamashita H, Imamura T, Hirono N, Hashimoto M, Tanimukai S, Kazui H, Hanihara T (1998) Cognitive loss in dementia with lewy bodies and Alzheimer disease. Arch Neurol 55: 1547–1552
St. Clair D, Norrman J, Perry R, Ytes C, Wilcock G, Brookes A (1994) Apolipoprotein E E4 allele frequency in patients with Lewy body dementia, Alzheimer’s disease and age-matched controls. Neurosci Lett 176: 45–46
Tanaka S, Chen X, Xia Y, Kang DE, Matoh N, Sundsmo M, Thomas RG, Katzman R, Thal LJ, Trojanowski JQ, Saitoh T, Ueda K, Masliah E (1998) Association of CYP2D microsatellite polymorphism with Lewy body variant of Alzheimer’s disease. Neurology 50: 1556–1562
Trètiakoff C (1919) Contribution à l’ètude de l’anatomie pathologique du locus niger de Soemmering. Thèse, Paris Nr. 293
Verghese J, Crystal HA, Dickson DW, Lipton RB (1999) Validity of clinical criteria for the diagnosis of dementia with Lewy bodies. Neurlogy 53: 1974–1982
Wakabayashi K, Hayshi S, Ishikawa A, Hayshi T, Okuizumi K, Tanaka H, Tsuji S, Takahashi H (1998) Autosomal dominant diffuse Lewy body disease. Acta Neuropathol (Berl) 96: 207–210
Walker Z, Grace J, Overshot R, Satarasinghe S, Swan A, Katona CL, McKeith IG (1999) Olanzapine in dementia with Lewy bodies: a clinical study. Int J Geriatr Psychiatry 14: 459–466
Weiner MF, Risser RC, Cullum CM, Horrig L, Withe III C, Speziale S, Rosenberg RN (1996) Alzheimer’s disease and its Lewy body variant: A clinical analysis of postmortem verified cases. Am J Psychiatry 153: 1269–1273
Yoshimura M (1983) Cortical changes in the parkinsonian brain: a contribution to the delineation of “diffuse Lewy body disease”. J Neurol 229: 17–32
Author’s address: Dr. G. Ransmayr, Department of Neurology, University of Innsbruck, Anichstrasse 35, A-6020 Innsbruck,Austria
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag Wien
About this paper
Cite this paper
Ransmayr, G. (2000). Dementia with Lewy bodies: prevalence, clinical spectrum and natural history. In: Riederer, P., et al. Advances in Research on Neurodegeneration. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6301-6_21
Download citation
DOI: https://doi.org/10.1007/978-3-7091-6301-6_21
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-83537-1
Online ISBN: 978-3-7091-6301-6
eBook Packages: Springer Book Archive